Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 1Phase 1/2 1

Status

Completed 37Unknown 9Terminated 6Withdrawn 3Recruiting 3Suspended 1Active not recruiting 1

Sponsor Class

OTHER 5NETWORK 1

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 6

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Leukemia 26Lymphoma 19Leukemia, Myeloid, Acute 19Myelodysplastic Syndromes 16Burkitt Lymphoma 15Lymphoma, Non-Hodgkin 12Lymphoma, Follicular 12Recurrence 11Leukemia, Lymphocytic, Chronic, B-Cell 11Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9Lymphoma, Large B-Cell, Diffuse 9Hodgkin Disease 9Graft vs Host Disease 9Leukemia, Myelomonocytic, Chronic 8Leukemia, Myeloid, Accelerated Phase 8Lymphoma, Mantle-Cell 7Leukemia, Myeloid, Chronic-Phase 7Multiple Myeloma 6Lymphoma, B-Cell, Marginal Zone 6Leukemia, Myelomonocytic, Juvenile 6Congenital Abnormalities 6Breast Neoplasms 6Blast Crisis 6Neoplasms, Plasma Cell 5Myeloproliferative Disorders 5Myelodysplastic-Myeloproliferative Diseases 5Lymphoma, Large-Cell, Immunoblastic 5Dendritic Cell Sarcoma, Interdigitating 5Urinary Bladder Neoplasms 4

Interventions

Trastuzumab 77Capecitabine 59Cyclophosphamide 54Paclitaxel 51Docetaxel 49Letrozole 44Fulvestrant 43Lapatinib 34Doxorubicin 31Carboplatin 31Vinorelbine 30Bevacizumab 29Anastrozole 28pembrolizumab 25exemestane 24Tamoxifen 23Gemcitabine 22Radiotherapy 21Albumin-Bound Paclitaxel 19Everolimus 17Taxes 16Epirubicin 15Ado-Trastuzumab Emtansine 13130-nm albumin-bound paclitaxel 13pertuzumab 12palbociclib 12liposomal doxorubicin 11Magnetic Resonance Spectroscopy 11Filgrastim 11Cisplatin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Terminated × Breast Neoplasms × Methotrexate × Clear all
NCT00074269 2023-06-05

Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Breast Cancer

University of California, San Diego

Phase 2 Terminated
5 enrolled 10 charts
Breast

Breast Neoplasms

NCT00925652 2022-01-19

ABCDE

Dana-Farber Cancer Institute

Phase 2 Terminated
55 enrolled 11 charts
Breast

Breast Neoplasms

NCT00296010 2021-02-23

CASA

ETOP IBCSG Partners Foundation

Phase 3 Terminated
77 enrolled
Breast

Breast Neoplasms

NCT00616122 2020-01-13

Sunitinib, Cyclophosphamide, and Methotrexate in Treating Patients With Metastatic Breast Cancer

University of California, San Francisco

Phase 1/2 Terminated
32 enrolled 10 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00194792 2017-07-11

Hormone Therapy and Combination Chemotherapy Before and After Surgery in Treating Patients With Stage I-IIIA Breast Cancer

University of Washington

Phase 2 Terminated
28 enrolled 9 charts
Breast

Breast Neoplasms

NCT01067989 2015-07-08

Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast Cancer

HaEmek Medical Center, Israel

Phase 2 Terminated
22 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡